Cargando…

A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation

INTRODUCTION: The differentiation of B cells into antibody-secreting plasma cells depends on cell division-coupled, epigenetic and other cellular processes that are incompletely understood. METHODS: We have developed a CRISPR/Cas9-based screen that models an early stage of T cell-dependent plasma ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Ermeng, Popp, Oliver, Salomon, Claudia, Mertins, Philipp, Kocks, Christine, Rajewsky, Klaus, Chu, Van Trung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849354/ https://www.ncbi.nlm.nih.gov/pubmed/36685499 http://dx.doi.org/10.3389/fimmu.2022.1083119

Ejemplares similares

B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
por: Schmidt, Kristin, et al.
Publicado: (2020)

CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia
por: Tran, Ngoc Tung, et al.
Publicado: (2020)

Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators
por: Le, Tuan Anh, et al.
Publicado: (2022)

sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing
por: Graf, Robin, et al.
Publicado: (2019)

Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2020)

Comprehensive CRISPR-Cas9 screen identifies factors which are important for plasmablast development
por: Pinter, Theresa, et al.
Publicado: (2022)

Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2019)

Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
por: Chu, Van Trung, et al.
Publicado: (2016)

Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
por: Zhang, Shuzhong, et al.
Publicado: (2020)

Efficient and Precise CRISPR/Cas9-Mediated MECP2 Modifications in Human-Induced Pluripotent Stem Cells
por: Le, Thi Thanh Huong, et al.
Publicado: (2019)

A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors
por: Klein, Klara, et al.
Publicado: (2021)

Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
por: Tran, Ngoc-Tung, et al.
Publicado: (2019)

CRISPR/Cas9 screening using unique molecular identifiers
por: Schmierer, Bernhard, et al.
Publicado: (2017)

Corrigendum: Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
por: Tran, Ngoc-Tung, et al.
Publicado: (2020)

Screening and Identification of the First Non-CRISPR/Cas9-Treated Chinese Miniature Pig With Defective Porcine Endogenous Retrovirus pol Genes
por: Ma, Yuyuan, et al.
Publicado: (2022)

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era
por: Weatherley, Daryl Anne Victoria, et al.
Publicado: (2017)

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
por: Huang, Rih-Sheng, et al.
Publicado: (2020)

Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma
por: Christodoulou, Eirini, et al.
Publicado: (2020)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
por: Wei, Yuhao, et al.
Publicado: (2022)

Establishment of a CRISPR/Cas9 knockout library for screening type I interferon-inducible antiviral effectors in pig cells
por: Dang, Wen, et al.
Publicado: (2022)

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018)

Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy
por: Xu, Yanxin, et al.
Publicado: (2022)

Precise CRISPR-Cas–mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells
por: Tran, Ngoc Tung, et al.
Publicado: (2022)

A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors
por: Katigbak, Alexandra, et al.
Publicado: (2016)

CRISPR/Cas9 based blockade of IL-10 signaling impairs lipid and tissue homeostasis to accelerate atherosclerosis
por: Shi, Haozhe, et al.
Publicado: (2022)

Efficient and stable CRISPR/Cas9-mediated genome-editing of human type 2 innate lymphoid cells
por: Audouze-Chaud, Johanne, et al.
Publicado: (2023)

Refined control of CRISPR-Cas9 gene editing in Clostridium sporogenes: the creation of recombinant strains for therapeutic applications
por: Kubiak, Aleksandra M., et al.
Publicado: (2023)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
por: Bahrami, Ehsan, et al.
Publicado: (2023)

Orthologous CRISPR-Cas9 enzymes for Combinatorial Genetic Screens
por: Najm, Fadi J, et al.
Publicado: (2017)

Survival and Evolution of CRISPR–Cas System in Prokaryotes and Its Applications
por: Shabbir, Muhammad Abu Bakr, et al.
Publicado: (2016)

Advances in CRISPR/Cas gene therapy for inborn errors of immunity
por: Liu, Xinyi, et al.
Publicado: (2023)

Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
por: Oakes, Benjamin L, et al.
Publicado: (2016)

Development and characterization of a CRISPR/Cas9-mediated RAG1 knockout chicken model lacking mature B and T cells
por: Lee, Kyung Youn, et al.
Publicado: (2022)

GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens
por: Rauscher, Benedikt, et al.
Publicado: (2017)

CRISPR/Cas9-mediated genome editing in nonhuman primates
por: Kang, Yu, et al.
Publicado: (2019)

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity
por: Estoppey, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dcl7ca12mecami17lne86udcvu